A study by Yuhui Wu on the effect of ISM1 in CRC showed that ISM1 was highly associated with immune-related pathways, such as the IL-2/STAT5 and IL-6/JAK/STAT3 signaling pathways [107]. This evidence concerns the gene IL6 and colorectal carcinoma.